Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04817891 · ClinicalTrials.gov registry record · NA

Stimulation of Cingulo-opercular Alertness Network

A NA study of Lewy Body Disease and Lewy Body Dementia With Behavioral Disturbance, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT04817891 is a NA study of Lewy Body Disease and Lewy Body Dementia With Behavioral Disturbance that has completed, run by University of Michigan. The registered enrollment target is 15 participants, below the 483-participant average among 6 other Lewy Body Disease trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04817891, a NA study of Lewy Body Disease and Lewy Body Dementia With Behavioral Disturbance, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

Fluctuations in alertness are very common in persons with Lewy body dementias and are a major source of disability. Changes in a chemical messenger molecule called acetylcholine within certain brain regions may play a role in these fluctuations. We propose to test this hypothesis and also determine whether a non-invasive way of stimulating affected brain regions may be of relevance for future management of these fluctuations.

Interventions

  • DEVICE HD-tDCS

Study Locations (1)

Michigan

  • 4250 Plymouth Road (University of Michigan) - Ann Arbor

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2021-05-03
Est. Completion 2024-08-26
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT04817891

The ClinicalTrials.gov registry entry for NCT04817891 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 483-participant average among 6 other Lewy Body Disease trials with a reported enrollment target (97% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Lewy Body Disease appearing as the primary indexed condition, and to 1 intervention - of which HD-tDCS is the first listed.

NCT04817891 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT04817891 about?

NCT04817891 is a clinical study titled "Stimulation of Cingulo-opercular Alertness Network". Fluctuations in alertness are very common in persons with Lewy body dementias and are a major source of disability. Changes in a chemical messenger molecule called acetylcholine within certain brain regions may play a role in these fluctuations. We propose to test this hypothesis and also determine ...

What is the current status of trial NCT04817891?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2021-05-03. Estimated completion is 2024-08-26.

What conditions does trial NCT04817891 study?

This clinical trial studies the following conditions: Lewy Body Disease, Lewy Body Dementia With Behavioral Disturbance, Lewy Body Variant of Alzheimer Disease.

What interventions are being tested in trial NCT04817891?

The interventions under investigation include: HD-tDCS (DEVICE).

Who is sponsoring clinical trial NCT04817891?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04817891 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lewy Body Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.